glp 1 mast cell Glucagon and glucagon-like peptide-1 as novel anti-inflammatory and immunomodulatory compounds Mechanism of action of GLP-1

57 eNOS uncoupling and altered eNOS signaling Paradoxically, in most situations in which increased oxidative stress and endothelial dysfunction are encountered, the expression of eNOS has been shown to be increased rather than decreased

This central action provides a strong basis for its role in neuroprotection against biochemical insults and stress

Semaglutide or Tirzepatide, metabolic complement GLP-1 agonists address appetite and weight

Key takeaways Mounjaro is approved for Type 2 diabetes but is often used off-label for weight loss due to its appetite-suppressing effects

Additionally, advancements in drug delivery technologies are enhancing the bioavailability and efficacy of oral GLP-1 therapies, further fueling their market growth